248
Views
18
CrossRef citations to date
0
Altmetric
REVIEW

Susceptibility genes for coronary heart disease and myocardial infarction

&
Pages 136-142 | Received 24 Jun 2011, Accepted 04 Jul 2011, Published online: 30 Aug 2011

References

  • International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004;431:931–45.
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747–57.
  • Colditz GA, Stampfer MJ, Willett W, Rosner B, Spizer FE, Hennkens CH. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986;123:48–58.
  • Lewis D, Wang Q, Topol EJ. Ischemic heart disease. Nature Encyclopedia of Life Sciences 2002;10:508–15.
  • Shen G, Archacki SR, Wang Q. The molecular genetics of coronary artery and myocardial infarction. Acute Coronary Syndromes 2004;6:129–41.
  • Schildkraut JM, Myers RH, Cupples LA, Dan K, Kiel MA, William BK. Coronary risk associated with age and sex of parental heart disease in Framingham Study. Am J Cardiol. 1989;64:555–9.
  • Zipes DP, Wellens HJ. Sudden Cardiac death. Circulation 1998;98:2334–51.
  • Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global burden of disease study. Lancet 1997;1498–504.
  • Qing W. Molecular genetics of coronary artery disease. Curr Opin Cardiol. 2005;20:182–8.
  • Kullo IJ, Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med;4:558–69.
  • Topol EJ, Smith J, Plow EF, Wang QK. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet;15:R117–23.
  • D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, . General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743–53. Epub 2008 Jan 22.
  • Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2008;100:1037–41.
  • Janssens AC, van Duijn CM. Genome-based prediction of common diseases: Advances and prospects. Hum Mol Genet. 2008;17:166–73.
  • Mosca L. C-reactive protein—to screen or not to screen? N Engl J Med. 2002;20:1615–7.
  • Manolio T. Novel risk markers and clinical practice. N Engl J Med. 2003;17:1587–9.
  • Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, . American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Working Group. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: A scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation;115:2878–901.
  • Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, . comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 30:210–4.
  • Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity specific risk of myocardial infarction. Nat Genet 2006;38:68–74.
  • McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, . A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488–91.
  • Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science;316:1491–3.
  • Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature;447:661–78.
  • Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, . WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–53.
  • Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, . A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341–5.
  • Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331–6.
  • Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, Mangino M, . Cardiogenics Consortium. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008;117:1675–84.
  • Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, ., PROCARDIS Consortium. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008;17:806–14.
  • Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, Naing T, . Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol. 2009;29:1671–7.
  • Holdt LM, Beutner F, Scholz M, Gielen S, Gäbel G, Bergert H, . ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol. 2010;30:620–7.
  • Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, . Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650–4.
  • Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, . Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 2004;429:72–5.
  • Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y, . A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006;38:921–5.
  • Ozaki K, Sato H, Inoue K, Tsunoda T, Sakata Y, Mizuno H, . SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet. 2009;41:329–933.
  • Clarke R, Xu P, Bennett D, Lewington S, Zondervan K, Parish S, ., International Study of Infarct Survival (ISIS) Collaborators. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2006;2:e107.
  • Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, . Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161–9.
  • Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;4:334–41.
  • Trégouët DA, König IR, Erdmann J, Munteanu A, Braund PS, Hall AS, ., Wellcome Trust Case Control Consortium; Cardiogenics Consortium. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet. 2009;41:283–5.
  • Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, . Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342–7.
  • Hinohara K, Nakajima T, Yasunami M, Houda S, Sasaoka T, Yamamoto K, . Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease. Hum Genet. 2009;126:539–47.
  • Ripatti S, Tikkanen E, Orho-Melander M. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010;376:1393–400.
  • Sandhu M, Wood A, Young E. Genomic risk prediction. Lancet 2010;376:1366–7.
  • Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, . Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium.. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies. Lancet 2011;10:61996–4.
  • Lotta LA, Peyvandi F. Addressing the complexity of cardiovascular disease by design. Lancet 2011;377:356–8.
  • Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, . Meta-analysis of genome-wide association studies in>80,000 subjects identifies multiple loci for C-reactive protein. Circulation 2011;123:731–8.
  • Erdmann J, Grosshennig A, Braund PS, König IR, Hengstenberg C, Hall AS, ., Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics Consortium. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41:280–2.
  • Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, . 9P21 DNA variants associated with coronary artery impair interferon-Y signaling response. Nature Rev Genet. 2011;3:264–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.